Acute unilateral ischemic renal injury induces progressive renal inflammation, lipid accumulation, histone modification, and "end-stage" kidney disease

American Journal of Physiology - Renal Physiology

Volumn 301, Issue 6, 2011, Pages

  Zager, Richard A ^a,b   Johnson, Ali C M ^a   Becker, Kirsten ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Acute kidney injury; Progressive renal disease

Indexed keywords

CHOLESTEROL; COLLAGEN TYPE 3; HEME OXYGENASE 1; INTERLEUKIN 10; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; TRANSFORMING GROWTH FACTOR BETA1; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE ACTIVATION; GENE EXPRESSION; GENE INDUCTION; HISTONE ACETYLATION; HISTONE MODIFICATION; KIDNEY ISCHEMIA; LIPID STORAGE; LIPOTOXICITY; MALE; MOUSE; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL;

EID: 82755172460     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00431.2011     Document Type: Article

References (58)

1. Adcock IM, Ito K, Barnes PJ. Histone deacetylation: an important mechanism in inflammatory lung diseases (Review). COPD 2: 445-455, 2005.
2. Alves BN, Marshall K, Tamang DL, Leong J, Redelman D, Elliott V, Lowe ME, Hudig D. Lipid-dependent cytotoxicity by the lipase PLRP2 and by PLRP2-positive cytotoxic T lymphocytes (CTLs). Cell Biochem Funct 27: 296-308, 2009.
3. Bonventre JV. Pathophysiology of acute kidney injury: roles of potential inhibitors of inflammation (Review). Contrib Nephrol 156: 39-46, 2007.
4. Chen F, Smith R, Gu YZ, Collins ND, Nioi P. Toxicoepigenetic alteration of the kidney injury molecule 1 gene in gentamicin-exposed rat kidney. Toxicol Sci 117: 375-380, 2010.
5. Christo JS, Rodrigues AM, Mouro MG, Cenedeze MA, Simoes MJ, Schor N, Higa EM. Nitric oxide (NO) is associated with gentamicin (GENTA) nephrotoxicity and the renal function recovery after suspension of GENTA treatment in rats. Nitric Oxide 24: 77-83, 2011.
6. Devarajan P. Biomarkers for the early detection of acute kidney injury. Curr Opin Pediatr 23: 194-200, 2011.
7. Finn WF. Enhanced recovery from postischemic acute renal failure. Micropuncture studies in the rat. Circ Res 46: 440-448, 1980.
8. Finn WF. Recovery from acute renal failure. In: Acute Renal Failure, edited by Brenner BM and Lazarus JM. New York: Churchill Livingstone, 1988, p. 875-918.
9. Finn WF, Chevalier RL. Recovery from postischemic acute renal failure in the rat. Kidney Int 16: 113-123, 1979.
10. Finn WF, Fernandez-Repollet E, Goldfarb D, Iaina A, Eliahou HE. Attenuation of injury due to unilateral renal ischemia: delayed effects of contralateral nephrectomy. J Lab Clin Med 103: 193-203, 1984.
11. Ishani A, Xue JL, Himmelfarb J, Eggers PW, Kimmel PL, Molitoris BA, Collins AJ. Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol 20: 223-228, 2009.
12. Jarmi T, Agarwal A. Heme oxygenase and renal disease (Review). Curr Hypertens Rep 11: 56-62, 2009.
13. Johnson AC, Stahl A, Zager RA. Triglyceride accumulation in injured renal tubular cells: alterations in both synthetic and catabolic pathways. Kidney Int 67: 2196-2209, 2005.
14. Kim HJ, Moradi H, Yuan J, Norris K, Vaziri ND. Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney. Am J Physiol Renal Physiol 296: F1297-F1306, 2009.
15. Kjellstrand CM, Ebben J, Davin T. Time of death, recovery of renal function, development of chronic renal failure and need for chronic hemodialysis in patients with acute tubular necrosis. Trans Am Soc Artif Intern Organs 27: 45-50, 1981.
16. Kjellstrand CM, Gornick C, Davin T. Recovery from acute renal failure. Clin Exp Dial Apheresis 5: 143-161, 1981.
17. Koletsky S. Effects of temporary interruption of renal circulation in rats. AMA Arch Pathol 58: 592-603, 1954.
18. Koyama T, Kume S, Koya D, Araki SI, Isshiki K, Chin-Kanasaki M, Sugimoto T, Haneda M, Sugaya T, Kashiwagi A, Maegawa H, Uzu T. SIRT3 attenuates palmitate-induced ROS production and inflammation in proximal tubular cells. Free Radic Biol Med prepublished online May 30, 2011; doi:10.1016/j.freeradbiomed.2011.05.028, 9999.
19. Lakhal K, Ehrmann S, Chaari A, Laissy JP, Régnier B, Wolff M, Pajot O. Acute Kidney Injury Network definition of contrast-induced nephropathy in the crically ill: incidence and outcome. J Crit Care prepublished online July 5, 2011; doi:10.1016/j.crci2011.05.010, 9999.
20. Li S, Gokden N, Okusa MD, Bhatt R, Portilla D. Anti-inflammatory effect of fibrate protects from cisplatin-induced ARF. Am J Physiol Renal Physiol 289: F469-F480, 2005.
21. Listenberger LL, Han X, Lewis SE, Cases S, Farese RV Jr, Ory DS, Schaffer JE. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc Natl Acad Sci USA 100: 3077-3082, 2003.
22. Lo LJ, Go AS, Chertow GM, McCulloch CE, Fan D, Ordonez JD, Hsu CY. Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int 76: 893-899, 2009.
23. Malkusch W, Rehn B, Bruch J. Advantages of Sirius Red staining for quantitative morphometric collagen measurements in lungs. Exp Lung Res 21: 67-77, 1995.
24. Mifsud KR, Gutièrrez-Mecinas M, Trollope AF, Collins A, Saunderson EA, Reul JM. Epigenetic mechanisms in stress and adaption. Brain Behavior Immunity prepublished online June 14, 2011; doi:10.1016/jbbi.2011.06.005, 9999.
25. Nagothu KK, Bhatt R, Kaushal GP, Portilla D. Fibrate prevents cisplatininduced proximal tubule cell death. Kidney Int 68: 2680-2693, 2005.
26. Naito M, Bomsztyk K, Zager RA. Renal ischemia-induced cholesterol loading: transcription factor recruitment and chromatin remodeling along the HMG CoA reductase gene. Am J Pathol 174: 54-62, 2009.
27. Naito M, Zager RA, Bomsztyk K. BRG1 increases transcription of proinflammatory genes in renal ischemia. J Am Soc Nephrol 20: 1787-1796, 2009.
28. Nath KA. Heme oxygenase-1: a provenance for cytoprotective pathways in the kidney and other tissues (Review). Kidney Int 70: 432-443, 2006.
29. Nath KA, Croatt AJ, Haggard JJ, Grande JP. Renal response to repetitive exposure to heme proteins: chronic injury induced by an acute insult. Kidney Int 57: 2423-2433, 2000.
30. Nath KA, Croatt AJ, Warner GM, Grande JP. Genetic deficiency of Smad3 protects against murine ischemic acute kidney injury. Am J Physiol Renal Physiol prepublished online April 27, 2011; doi:10.1152/ajprenal.00162.2011,9999.
31. Pechman KR, De Miguel C, Lund H, Leonard EC, Basile DP, Mattson DL. Recovery from renal ischemia-reperfusion injury is associated with altered renal hemodynamics, blunted pressure natriuresis, and sodiumsensitive hypertension. Am J Physiol Regul Integr Comp Physiol 297: R1358-R1363, 2009.
32. Pergola PE, Raskin P, Toto RD, Meyer CJ, Huff JW, Grossman EB, Krauth M, Ruiz S, Audhya P, Christ-Schmidt H, Wittes J, Warnock DG. Bardoxolone methyl and kidney function in CKD with type 2 diabetes. N Engl J Med prepublished online June 24, 2011; doi:10.1056/NEJMoa1105351, 9999.
33. Perman JC, Bostrom P, Lindbom M, Lidberg U, Stahlman M, Hagg D, Lindskog H, Scharin TM, Omerovic E, Mattsson HL, Jeppsson A, Petursson P, Herlitz J, Olivecrona G, Strickland DK, Ekroos K, Olofsson SO, Boren J. The VLDL receptor promotes lipotoxicity and increases mortality in mice following an acute myocardial infarction. J Clin Invest 121: 2625-2640, 2011.
34. Sanz AB, Sanchez-Nino MD, Ramos AM, Moreno JA, Santamaria B, Ruiz-Ortega M, Egido J, Ortiz A. NF-kappaB in renal inflammation (Review). J Am Soc Nephrol 21: 1254-1262, 2010.
35. Schaffer JE. Lipotoxicity: when tissues overeat (Review). Curr Opin Lipid 14: 281-287, 2003.
36. Sharfuddin AA, Molitoris BA. Pathophysiology of ischemic acute kidney injury. Nature Rev Nephrol 7: 189-200, 2011.
37. Spurgeon-Pechman KR, Donohoe DL, Mattson DL, Lund H, James L, Basile DP. Recovery from acute renal failure predisposes hypertension and secondary renal disease in response to elevated sodium. Am J Physiol Renal Physiol 293: F269-F278, 2007.
38. Tadagavadi RK, Reeves WB. Endogenous IL-10 attenuates cisplatin nephrotoxicity: role of dendritic cells. J Immunol 185: 4904-4911, 2010.
39. Tanaka Y, Kume S, Araki S, Isshiki K, Chin-Kanasaki M, Sakaguchi M, Sugimoto T, Koya D, Haneda M, Kashiwagi A, Maegawa H, Uzu T. Fenofibrate, a PPARalpha agonist, has renoprotective effects in mice by enhancing renal lipolysis. Kidney Int 79: 871-882, 2011.
40. Tracz MJ, Juncos JP, Croatt AJ, Ackerman AW, Grande JP, Knutson KL, Kane GC, Terzic A, Griffin MD, Nath KA. Deficiency of heme oxygenase-1 impairs renal hemodynamics and exaggerates systemic inflammatory responses to renal ischemia. Kidney Int 72: 1073-1080, 2007.
41. Tracz MJ, Juncos JP, Grande JP, Croatt AJ, Ackerman AW, Rajagopalan G, Knutson KL, Badley AD, Griffin MD, Alam J, Nath KA. Renal hemodynamic, inflammatory, and apoptotic responses to lipopolysaccharide in HO-1 mice. Am J Pathol 170: 1820-1830, 2007.
42. Waikar SS, Curhan GC, Wald R, McCarthy EP, Chertow GM. Declining mortality in patients with acute renal failure, 1988 to 2002. J Am Soc Nephrol 17: 1143-1150, 2006.
43. Weinberg JM. Lipotoxicity (Review). Kidney Int 70: 1560-1566, 2006.
44. Wu QQ, Wang Y, Senitko M, Meyer C, Wigley WC, Ferguson DA, Grossman E, Chen J, Zhou XJ, Hartono J, Winterberg P, Chen B, Agarwal A, Lu CY. Bardoxolone methyl (BARD) ameliorates ischemic AKI and increases expression of protective genes Nrf2, PPARgamma, and HO-1. Am J Physiol Renal Physiol 300: F1180-F1192, 2011.
45. Xue JL, Daniels F, Star RA, Kimmel PL, Eggers PW, Molitoris BA, Himmelfarb J, Collins AJ. Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol 17: 1135-1142, 2006.
46. Zager RA. Uremia induces proximal tubular cytoresistance and heme oxygenase-1 expression in the absence of acute kidney injury. Am J Physiol Renal Physiol 296: F362-F368, 2009.
47. Zager RA, Andoh T, Bennett WM. Renal cholesterol accumulation: a durable response after acute and subacute renal insults. Am J Pathol 159: 743-752, 2001.
48. Zager RA, Burkhart KM, Johnson ACM, Sacks BM. Increased proximal tubular cholesterol content: implications for cell injury and "acquired cytoresistance". Kidney Int 56: 1788-1797, 1999.
49. Zager RA, Johnson AC, Hanson SY, Lund S. Acute nephrotoxic and obstructive injury primes the kidney to endotoxin-driven cytokine/chemokine production. Kidney Int 69: 1181-1188, 2006.
50. Zager RA, Johnson AC, Hanson SY, Shah VO. Acute tubular injury causes dysregulation of cellular cholesterol transport proteins. Am J Pathol 163: 313-320, 2003.
51. Zager RA, Johnson AC, Lund S. "Endotoxin tolerance": TNF-alpha hyperreactivity and tubular cytoresistance in a renal cholesterol loading state. Kidney Int 71: 496-503, 2007.
52. Zager RA, Johnson ACM. Renal ischemia-reperfusion injury upregulates histone-modifying enzyme systems and alters histone expression at proinflammatory/ profibrotic genes. Am J Physiol Renal Physiol 296: F1032-F1041, 2009.
53. Zager RA, Johnson ACM. Progressive histone alterations and proinflammatory gene activation: consequences of heme protein/iron-mediated proximal tubule injury. Am J Physiol Renal Physiol 298: F827-F837, 2010.
54. Zager RA, Johnson ACM, Hanson SY. Renal tubular triglyercide accumulation following endotoxic, toxic, and ischemic injury. Kidney Int 67: 111-121, 2005.
55. Zager RA, Johnson ACM, Lund S. Uremia impacts renal inflammatory cytokine gene expression in the setting of experimental acute kidney injury. Am J Physiol Renal Physiol 297: F961-F970, 2009.
56. Zager RA, Shah VO, Shah HV, Zager PG, Johnson AC, Hanson S. The mevalonate pathway during acute tubular injury: selected determinants and consequences. Am J Pathol 161: 681-692, 2002.
57. Zager RA, Johnson A, Anderson K. Plasma membrane cholesterol: a critical determinant of cellular energetics and tubular resistance to attack. Kidney Int 58: 193-205, 2000.
58. Zhu X, Zhang Y, Bjornsdottir G, Liu Z, Quan A, Constanzo M, Dávila López M, Westholm JO, Ronne H. Histone modifications influence mediator interactions with chromatin. Nucleic Acids Res prepublished online July 8, 2011; doi:10.1093/nar/gkr551, 9999.